Diana Karcheva-Bahchevanska

Dr. Diana Karcheva-Bahchevanska

Pharmacognosy and Pharmaceutical Chemistry, Medical University Plovdiv, Plovdiv, Bulgaria
orcid
Assoc. Prof. of Pharmacognosy and Phytochemistry

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Velislava TodorovaVelislava Todorova
Velislava Todorova
KIKalin Valentinov Ivanov
Kalin Valentinov Ivanov
Delattre CedricDelattre Cedric
Delattre Cedric
VNVanya Nalbantova
Vanya Nalbantova
Diana Karcheva-BahchevanskaDiana Karcheva-Bahchevanska
Diana Karcheva-Bahchevanska
Stanislava IvanovaStanislava Ivanova
Stanislava Ivanova
Adaptogens are synthetic compounds (bromantane, levamisole, aphobazole, bemethyl, etc.) or plant extracts that have the ability to enhance the body’s stability against physical loads without increasing oxygen consumption. Extracts from Panax ginseng, Eleutherococcus senticosus, Rhaponticum carthamoides, Rhodiola rosea, and Schisandra chinensis are considered to be naturally occurring adaptogens and, in particular, plant adaptogens. The aim of this study is to evaluate the use of plant adaptogens in the past and now, as well as to outline the prospects of their future applications. The use of natural adaptogens by humans has a rich history—they are used in recovery from illness, physical weakness, memory impairment, and other conditions. About 50 years ago, plant adaptogens were first used in professional sports due to their high potential to increase the body’s resistance to stress and to improve physical endurance. Although now many people take plant adaptogens, the clinical trials on human are limited. The data from the meta-analysis showed that plant adaptogens could provide a number of benefits in the treatment of chronic fatigue, cognitive impairment, and immune protection. In the future, there is great potential to register medicinal products that contain plant adaptogens for therapeutic purposes.

18 February 2022 in Viruses
Verified
Journal Article
Open access
PDF file
HCHadrien Claus-Desbonnet
Hadrien Claus-Desbonnet
ENElsa Nikly
Elsa Nikly
VNVanya Nalbantova
Vanya Nalbantova
Diana Karcheva-BahchevanskaDiana Karcheva-Bahchevanska
Diana Karcheva-Bahchevanska
Stanislava IvanovaStanislava Ivanova
Stanislava Ivanova
Delattre CedricDelattre Cedric
Delattre Cedric
In the current context of the COVID-19 pandemic, it appears that our scientific resources and the medical community are not sufficiently developed to combat rapid viral spread all over the world. A number of viruses causing epidemics have already disseminated across the world in the last few years, such as the dengue or chinkungunya virus, the Ebola virus, and other coronavirus families such as Middle East respiratory syndrome (MERS-CoV) and severe acute respiratory syndrome (SARS-CoV). The outbreaks of these infectious diseases have demonstrated the difficulty of treating an epidemic before the creation of vaccine. Different antiviral drugs already exist. However, several of them cause side effects or have lost their efficiency because of virus mutations. It is essential to develop new antiviral strategies, but ones that rely on more natural compounds to decrease the secondary effects. Polysaccharides, which have come to be known in recent years for their medicinal properties, including antiviral activities, are an excellent alternative. They are essential for the metabolism of plants, microorganisms, and animals, and are directly extractible. Polysaccharides have attracted more and more attention due to their therapeutic properties, low toxicity, and availability, and seem to be attractive candidates as antiviral drugs of tomorrow.

8 December 2021 in Foods
Verified
Journal Article
Open access
PDF file
Stanislava IvanovaStanislava Ivanova
Stanislava Ivanova
Delattre CedricDelattre Cedric
Delattre Cedric
Diana Karcheva-BahchevanskaDiana Karcheva-Bahchevanska
Diana Karcheva-Bahchevanska
NBNiko Benbasat
Niko Benbasat
VNVanya Nalbantova
Vanya Nalbantova
KIKalin Valentinov Ivanov
Kalin Valentinov Ivanov
According to the World Health Organization, obesity has nearly tripled since the 1970s. Obesity and overweight are major risk factors for cardiovascular diseases, diabetes, inflammatory-mediated diseases, and other serious medical conditions. Moreover, recent data suggest that obesity, overweight, diabetes, and cardiovascular diseases are risk factors for COVID-19-related mortality. Different strategies for weight control have been introduced over the last two decades. Unfortunately, these strategies have shown little effect. At the same time, many studies show that plants might be the key to a successful strategy for weight control. Following the PRISMA guidelines for conducting systematic reviews, a search was conducted in PubMed, Web of Science, Scopus, and Embase using the following keywords: obesity, globesity, vegan, plant-based diet, etc. Our results show that vegan diets are associated with improved gut microbiota symbiosis, increased insulin sensitivity, activation of peroxisome proliferator-activated receptors, and over-expression of mitochondrial uncoupling proteins. The key features of this diet are reduced calorie density and reduced cholesterol intake. The combination of these two factors is the essence of the efficiency of this approach to weight control. Our data suggest that plant-based/vegan diets might play a significant role in future strategies for reducing body weight.

13 November 2024 in Molecules
Verified
Journal Article
Open access
PDF file
SPStela Pashova
Stela Pashova
Diana Karcheva-BahchevanskaDiana Karcheva-Bahchevanska
Diana Karcheva-Bahchevanska
KIKalin Valentinov Ivanov
Kalin Valentinov Ivanov
Stanislava IvanovaStanislava Ivanova
Stanislava Ivanova
The genus Stachys represents one of the most extensive genera within the subfamily Lamioideae and ranks as one of the largest genera in the Lamiaceae family. Many Stachys species are associated with a rich history in traditional medicine across various cultures, and their extracts and essential oils are rich in non-volatile and volatile compounds. Because of their complex profile of bioactive substances, Stachys members are considered to possess an extensive spectrum of therapeutic properties, including antioxidant, anti-inflammatory, analgesic, antibacterial, cytotoxic, and wound-healing effects, as well as benefits for memory enhancement, lipid profile regulation, blood glucose control, and weight management. Despite the wide distribution and chemical diversity of the genus, studies on its biological activities remain limited. The aim of this review is to summarize the most relevant data from studies on the bioactive compounds, traditional uses, and pharmacological properties of Stachys species found in databases such as Science Direct, PubMed, and Scopus. Specific keywords were used in the search strategy, including “bioactive compounds”, “Stachys”, “Lamiaceae”, “Stachys extract”, “Stachys essential oil”, “traditional uses”, “chemical composition”, “therapeutic potential”, “clinical trials”, “in vivo studies”, “in vitro studies”. The search strategy was performed according to the guidelines for Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Data from 171 studies were included. The manuscript highlights the drug-discovery potential of Stachys species, emphasizing their potential applications in medicine, cosmetics, dietary supplements, and the food industry. Moreover, it provides important data that could assist Stachys research programs.

13 January 2023 in International Journal of Analytical Chemistry
Verified
Journal Article
Open access
PDF file
Velislava TodorovaVelislava Todorova
Velislava Todorova
KIKalin Valentinov Ivanov
Kalin Valentinov Ivanov
YGYoana Georgieva
Yoana Georgieva
Diana Karcheva-BahchevanskaDiana Karcheva-Bahchevanska
Diana Karcheva-Bahchevanska
Stanislava IvanovaStanislava Ivanova
Stanislava Ivanova
The main aim of this study was to assess the differences in the chemical composition of essential oil from biocultivated Lavandula angustifolia in the Thracian Lowland floristic region, Bulgaria, and commercially available products from Bulgarian markets. Following the analytical results conducted with gas chromatography-mass spectrometry, we have established some differences in the chemical composition of the tested samples. The essential oil of biocultivated lavender contained 35 compounds, which represent 94.13 of the total oil. Samples from commercial products contained 2842 compounds that represent 93.0398.69 of the total oil. All the examined samples were rich in monoterpene hydrocarbons (1.6812.77), oxygenated monoterpenes (70.4287.96), sesquiterpene hydrocarbons (4.0313.78), and oxygenated sesquiterpenes (0.140.76). The dominant components in all examined samples were linalool (20.045.0) and linalyl acetate (20.7939.91). All the examined commercial samples contained linalool and linalyl acetate as was described in the European Pharmacopoeia, but in one of the samples, the quality of linalyl acetate is lower than that recommended in the European Pharmacopoeia.

1 June 2017 in Folia Medica
Verified
Journal Article
Open access
PDF file
Diana Karcheva-BahchevanskaDiana Karcheva-Bahchevanska
Diana Karcheva-Bahchevanska
Paolina LukovaPaolina Lukova
Paolina Lukova
MNMariana M. Nikolova
Mariana M. Nikolova
RMRumen D. Mladenov
Rumen D. Mladenov
IIIlia N. Iliev
Ilia N. Iliev
Background:Vaccinium myrtillusL. is a species belonging to the genusVacciniumof the familyEricaceae. Bilberries have drawn attention due to the multiple benefits for the human health, including antioxidant, anti-inflammatory, anticancer, anti-neurodegenerative, and cardioprotective effects. Recently, bilberries were shown to inhibit the activity of carbohydrate-hydrolysing enzymes that can help reduce the intensity of the metabolic syndrome and prevent type 2 diabetes.Aim:In this study, we investigated theα-glucosidase and amyloglucosidase inhibitory activities of polyphenol-rich extracts from fruit ofVaccinium myrtillusL. from different regions in Bulgaria.Materials and methods:The total phenolic content was determined spectrophotometrically using the Folin-Ciocalteu method. With HPLC analysis, phenolic acid composition of extracts was assessed. Enzymatic inhibitory activities were determined according to the methodology by Borooah et al. (1961), and Dewi et al. (2007). Amyloglucosidase assay andα-glucosidase assay were used to measure the inhibition potential of bilberries’ extracts.Results:Phenolic compound content ranged from 1299.60 mg to 510.88 mg GAE/100 g for organic extracts and from 453.63 mg to 290.83 mg GAE/100 g for aqueous extracts. Based on qualitative HPLC analyses, gallic acid and chlorogenic acid were found to be among the major phenolic acids present in bilberries. Methanol and aqueous extracts there were found to be effective inhibitors ofα-glucosidase with an IC50value of 20 μg GAE/ml and 55 μg GAE/ml, respectively.Conclusion:The inhibitory activity of bilberries’ extracts towardsα-glucosidase offers the patients with type 2 diabetes the opportunity to manage their own glycaemic levels with a diet.